# A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies

> **NCT03607643** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Leaf Vertical Inc.** · enrollment: 160 (estimated)

## Conditions studied

- Cancer of Pancreas
- Cancer of Liver
- Cancer of Rectum
- Cancer of Colon
- Cancer, Gall Bladder
- Myeloma Multiple
- Glioblastoma Multiforme

## Interventions

- **DRUG:** Cannabidiol
- **DRUG:** Bortezomib
- **DRUG:** Leucovorin
- **DRUG:** 5-FU
- **DRUG:** Oxaliplatin
- **DRUG:** Bevacizumab
- **DRUG:** Irinotecan
- **DRUG:** Gemcitabine
- **DRUG:** Temozolomide

## Key facts

- **NCT ID:** NCT03607643
- **Lead sponsor:** Leaf Vertical Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-01-15
- **Primary completion:** 2020-06-30
- **Final completion:** 2020-12-15
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2018-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03607643

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03607643, "A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03607643. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*